Skip to main content

#153466

Ruby-Mad2 Reporter Cell Line

Cat. #153466

Ruby-Mad2 Reporter Cell Line

Cat. #: 153466

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Eye

Model: Reporter

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jonathon Pines

Institute: University of Cambridge

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Ruby-Mad2 Reporter Cell Line
  • Research fields: Cell biology
  • Parental cell: RPE1
  • Organism: Human
  • Tissue: Eye
  • Model: Reporter
  • Conditional: Yes
  • Description: RPE1 cell line in which the Ruby fluorescent protein has been knocked into one allele of the Mad2 gene.
  • Biosafety level: 1

Target Details

  • Target: Mad2

Handling

  • Format: Frozen
  • Growth medium: F12/DMEM (Sigma: D6241) + 2mM GlutaMAX ?‚™ (Invitrogen), 10% Foetal Bovine Serum (FBS) + 0.348% sodium bicarbonate; 37oC; 5% CO2.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Mycoplasma free: Yes

Related Tools

  • Related tools: Venus-Mad2 Reporter Cell Line [RPE1 Venus-Mad2/+ KI clone #1] ; Cyclin A2-Venus Reporter Cell Line [RPE1 cycA2-venus/+ KI clone D6] ; Cyclin B1-Venus Reporter Cell Line [RPE1 cycB1-venus/+ KI clone 20G11]

References

  • Collin et al. 2013. Nat Cell Biol. 15(11):1378-85. PMID: 24096242.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.